Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $800000.0.

  • Neurogene's Depreciation & Amortization (CF) changed 0.0% to $800000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 397.68%. This contributed to the annual value of $3.2 million for FY2024, which is 303.03% down from last year.
  • As of Q3 2025, Neurogene's Depreciation & Amortization (CF) stood at $800000.0, which was down 0.0% from $800000.0 recorded in Q2 2025.
  • In the past 5 years, Neurogene's Depreciation & Amortization (CF) ranged from a high of $855000.0 in Q4 2023 and a low of $749000.0 during Q1 2025
  • Over the past 3 years, Neurogene's median Depreciation & Amortization (CF) value was $800000.0 (recorded in 2023), while the average stood at $801818.2.
  • In the last 5 years, Neurogene's Depreciation & Amortization (CF) increased by 24.63% in 2024 and then tumbled by 798.53% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Depreciation & Amortization (CF) stood at $855000.0 in 2023, then fell by 7.6% to $790000.0 in 2024, then increased by 1.27% to $800000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $800000.0 in Q3 2025, compared to $800000.0 in Q2 2025 and $749000.0 in Q1 2025.